DK0529636T3 - Hidtil ukendte isatinoximderivater, deres fremstilling og anvendelse - Google Patents

Hidtil ukendte isatinoximderivater, deres fremstilling og anvendelse

Info

Publication number
DK0529636T3
DK0529636T3 DK92114654T DK92114654T DK0529636T3 DK 0529636 T3 DK0529636 T3 DK 0529636T3 DK 92114654 T DK92114654 T DK 92114654T DK 92114654 T DK92114654 T DK 92114654T DK 0529636 T3 DK0529636 T3 DK 0529636T3
Authority
DK
Denmark
Prior art keywords
cyclic
branched
alkyl
hydrogen
preparation
Prior art date
Application number
DK92114654T
Other languages
English (en)
Inventor
Frank Wotjen
Bjarne Hugo Dahl
Jorgen Drejer
Leif Helth Jensen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0529636T3 publication Critical patent/DK0529636T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK92114654T 1991-08-28 1992-08-27 Hidtil ukendte isatinoximderivater, deres fremstilling og anvendelse DK0529636T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75116591A 1991-08-28 1991-08-28
US83185192A 1992-02-05 1992-02-05

Publications (1)

Publication Number Publication Date
DK0529636T3 true DK0529636T3 (da) 1999-12-13

Family

ID=27115380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92114654T DK0529636T3 (da) 1991-08-28 1992-08-27 Hidtil ukendte isatinoximderivater, deres fremstilling og anvendelse

Country Status (18)

Country Link
EP (1) EP0529636B1 (da)
JP (1) JP3170584B2 (da)
KR (1) KR100277481B1 (da)
AT (1) ATE181552T1 (da)
AU (1) AU655672B2 (da)
CA (1) CA2076948C (da)
CZ (1) CZ282759B6 (da)
DE (1) DE69229461T2 (da)
DK (1) DK0529636T3 (da)
FI (1) FI107156B (da)
GE (1) GEP20002329B (da)
HU (2) HUT70753A (da)
MX (1) MX9204914A (da)
NO (1) NO301117B1 (da)
PL (1) PL170920B1 (da)
RU (1) RU2114827C1 (da)
SK (1) SK280578B6 (da)
WO (1) WO1993005043A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0664807B1 (en) 1992-10-13 1997-09-10 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
JP3439215B2 (ja) * 1993-05-13 2003-08-25 ノイロサーチ アクティーゼルスカブ Ampa拮抗薬およびそれを用いての治療方法
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
JP3164372B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ 融合インドール及びキノキサリン誘導体、その製造および使用
JP3164371B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ インドール−2,3−ジオン−3−オキシム誘導体、その製造および使用
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
FR2768624B1 (fr) 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
DE60041399D1 (de) 1999-05-19 2009-03-05 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
AU781067B2 (en) 2000-01-24 2005-05-05 Neurosearch A/S Isatine derivatives with neurotrophic activity
JP4505410B2 (ja) 2002-10-29 2010-07-21 サングキュンクワン ユニヴァースィティ モルヒネへの心理的依存又は耐性を防止及び処置するのに有効成分としてベルベリンを含有する医薬組成物
CN101346375B (zh) 2005-11-23 2013-04-10 阿罗斯药物有限责任公司 调节门离子通道用组合物和方法
MX2015007710A (es) * 2012-12-19 2015-09-23 Bayer Cropscience Ag Indanilcarboxamidas difluorometil-nicotinicas.
CN106061938B (zh) * 2014-02-28 2019-04-12 住友化学株式会社 2-(卤代甲基)-3-甲基硝基苯的制造方法
BR112018068688B1 (pt) 2016-03-17 2023-02-14 Fmc Corporation Processo para converter enantiômero s em sua forma racêmica, composto e uso do mesmo
CN112266367B (zh) * 2017-11-15 2023-12-08 中山光禾医疗科技有限公司 光交联水凝胶材料的制备、原料、产品及应用
CN108912127B (zh) * 2018-08-27 2019-12-10 青岛农业大学 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use

Also Published As

Publication number Publication date
FI940889A0 (fi) 1994-02-25
PL170920B1 (pl) 1997-02-28
NO940676L (da) 1994-04-27
CZ39594A3 (en) 1994-11-16
JP3170584B2 (ja) 2001-05-28
CA2076948A1 (en) 1993-03-01
WO1993005043A1 (en) 1993-03-18
EP0529636B1 (en) 1999-06-23
GEP20002329B (en) 2000-12-25
FI107156B (fi) 2001-06-15
AU655672B2 (en) 1995-01-05
ATE181552T1 (de) 1999-07-15
MX9204914A (es) 1993-07-01
DE69229461D1 (de) 1999-07-29
FI940889A (fi) 1994-02-25
NO301117B1 (no) 1997-09-15
SK280578B6 (sk) 2000-04-10
NO940676D0 (no) 1994-02-25
HU211632A9 (en) 1995-12-28
CZ282759B6 (cs) 1997-09-17
DE69229461T2 (de) 1999-10-21
CA2076948C (en) 2002-04-16
SK23894A3 (en) 1994-12-07
HU9400595D0 (en) 1994-05-30
HUT70753A (en) 1995-10-30
EP0529636A1 (en) 1993-03-03
RU2114827C1 (ru) 1998-07-10
JPH06510056A (ja) 1994-11-10
KR100277481B1 (ko) 2001-02-01
AU2482092A (en) 1993-04-05

Similar Documents

Publication Publication Date Title
DK0529636T3 (da) Hidtil ukendte isatinoximderivater, deres fremstilling og anvendelse
DE69201068T2 (de) Hydrazonderivate, ihre Herstellung und Verwendung.
RU94019425A (ru) Производные изатиноксима, способ их получения, фармацевтическая композиция и способ лечения
NO903148L (no) Hemoreguleringspeptider.
DE69313866T2 (de) Chinoxalinderivate als eaa antagonisten
ATE121395T1 (de) Cumarinderivate, ihre herstellung und ihre verwendung zur behandlung von zerebrovaskulären störungen.
DK0633262T3 (da) Hidtil ukendte isatinoximderivater samt fremstilling og anvendelse heraf
ATE143659T1 (de) Neue isatineoxime derivate, ihre herstellung und verwendung
ATE115537T1 (de) Biphenyl-5,5'-bis-alkansäurederivate, deren herstellung und verwendung.
FR2565972B1 (fr) Preparation des derives d'amines
DE68915595D1 (de) Verwendung von Isoxazolinonen als cerebro-aktive Medikamente.
DE69203732D1 (de) Substituierte Alkensäure und ihre Derivate.
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö